FRONTIER CAPITAL MANAGEMENT CO LLC
BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$9.36B2026 Q3
Positions297
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.13.8%
What Changed This Quarter?
Top Holdings
FTAI
FTAI Aviation
1.8%
DT
Dynatrace
1.6%
LSCC
Lattice Semiconductor
1.5%
HALO
Halozyme Therapeutics
1.4%
ASH
Ashland
1.4%
AKAM
Akamai Technologies
1.4%
ALK
Alaska Air
1.3%
TGTX
TG Therapeutics
1.2%
New / Increased
19 new · 113 increased
SNEW
Sentinelone
1.0%
MMEDNEW
Minimed
0.7%
HLINEW
Houlihan Lokey
0.4%
BUSENEW
First Busey
0.3%
NNNNEW
NNN REIT
0.2%
HALO
Halozyme Therapeutics
1.4%
+248.8%
TGTX
TG Therapeutics
1.2%
+450.6%
DT
Dynatrace
1.6%
+56.2%
Reduced / Exited
154 reduced · 22 sold out
P
Everpure
0.5%
-65.9%
MDB
Mongodb
0.3%
-74.0%
GVA
Granite Constr
0.6%
-56.1%
LRN
Stride
0.3%
-65.6%
UTHR
United Therapeutics
0.6%
-47.6%
GTXEXIT
Garrett Motion
0.5%
ACVAEXIT
Acv Auctions
0.4%
Apogee Therap…EXIT
Apogee Therapeutics
0.4%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.